Dataset for The cost of delivering COVID-19 vaccines in Mozambique

This study is part of a multi-country research project that utilizes standardized methods to generate cost evidence on the delivery of COVID-19 (C19) vaccines in Vietnam, Bangladesh, and the Philippines in Asia, and Mozambique, Côte d’Ivoire, the Democratic Republic of Congo, and Uganda in Africa. his was a retrospective, bottom-up costing study that estimated the financial and economic costs of delivering C19 vaccines from March 2021 to February 2022. Costs were estimated for the initial low-volume period from March to April 2021 (Phase I) as well as for the high-volume period of December 2021 to February 2022. The study was conducted from a payer perspective, including costs incurred by health service providers, the Ministry of Health (MOH) and development partners at all levels of the health system. In partnership wiht the University Eduardo Mondlane (UEM) data was collected retrospectively at health facilities in May-August 2022 from a purposively selected sample of 27 vaccination sites within six districts and two provinces (Maputo Province and Nampula), as well as from district and provincial health offices, the Expanded Program on Immunization (EPI) at the MOH, and from development partners. Costs were disaggregated across program activities and resource types to analyze cost drivers. Volume-weighted average unit costs were estimated for each administrative level and then aggregated to obtain the overall volume-weighted cost per dose.